Patients treated with omalizumab and mepolizumab exhibited a reduction in the frequency of ABRS, but these findings did not reach statistical significance.
← all excerpts
Association Between Biologic Therapy and Reduced Acute Rhinosinusitis Episodes: A Retrospective Database Study.
1
—
—